entertainment -WSS

entertainment

author：knowledge 2025-10-01 23:38:43 - browse：7

The bacterium A. baylyi was engineered to detect a common cancer mutation. Courtesy of Josephine Wright

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

Or, rather, a cup of yogurt — containing engineered bacteria that can detect and deliver a treatment for colorectal polyps or cancer. Worthley and colleagues at the University of California, San Diego, and the University of Adelaide published results in Science on Thursday that show they are one step closer to that far-off dream. In their paper, the researchers show a proof-of-concept engineered bacterium that can detect cancer DNA in the guts of mice and react to it by turning on certain cellular circuitry.

“I think it’s really cool. It introduces a new concept for how you can use cells as a sensor for something happening inside other cells,” said Mikhail Shapiro, a chemical and medical engineer at the California Institute of Technology who did not work on the study. “That can flip a switch inside those cells. In this case, it’s used for diagnostic output, but in principle it could be used for other things.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： DeSantis says Trump could've 'come out more forcefully' during Jan. 6

focus

WSS

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Elevance, private equity launch primary care company

After gene therapy, two congenitally deaf children hear for the first time

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Twill hunts for pharma partner to market its depression app

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

focus

entertainment

explore

Psychedelics group wrestles with new pharma identity

Making AI in medicine accessible to smaller, and rural hospitals

Anesthesiologist group: stop taking Ozempic before surgery

Study: People of West African ancestry at greater risk of cardiac amyloidosis

How one medical school became remarkably diverse

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Drug repurposing or repositioning? The language matters

H5N1 communication has been strictly for the birds

Novavax promises a turnaround & Lilly roils the obesity market

Researchers on aging grapple with how to calculate biological age

leisure time

BridgeBio heart drug succeeds in pivotal study

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Flagship, Pfizer team up in deal worth up to $7 billion

Apple Watch's A

US soldier in North Korean custody after crossing DMZ line

focus

hotspot

knowledge

explore